Search PDMR transactions

Notifier
Name
Keith Alexander
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Keith Alexander
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name
ExpreS2ion Biotech Holding AB
LEI
549300FJK50P1ORYJC45
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Warrant ExpreS2ion Biotech Holding T04 SE0014958328 Issue of instrument 2,136 Quantity 0.00 SEK 16/11/2020 NASDAQ STOCKHOLM AB
Warrant ExpreS2ion Biotech Holding T05 SE0014958336 Issue of instrument 2,136 Quantity 0.00 SEK 16/11/2020 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
ExpreS2ion Biotech Holding T04 SE0014958328 Issue of instrument 16/11/2020 NASDAQ STOCKHOLM AB 2,136 (Quantity) 0.00 SEK
ExpreS2ion Biotech Holding T05 SE0014958336 Issue of instrument 16/11/2020 NASDAQ STOCKHOLM AB 2,136 (Quantity) 0.00 SEK
<< Back